SCYNEXIS, Inc. is a chemistry-focused drug discovery and development company headquartered in Research Triangle Park, North Carolina. Its scientists have extensive experience in the life sciences industry having, together and individually, been involved in the discovery of innovative medicines over a broad range of therapy areas.
In the discovery phase SCYNEXIS offers its services primarily in the form of integrated research teams consisting of medicinal chemists, computational chemists, analytical chemists and bioanalytical scientists to work on a collaborative basis with our customers on projects from hit to candidate selection. SCYNEXIS project leaders of these multi-disciplinary teams are knowledgeable scientists with years of industry experience. They coordinate and communicate key activities and drive resources to achieve success. SCYNEXIS research teams use powerful, proprietary technologies such as the HEOS® Software Suite, MEDCHEM-FACTORY® and KIT™ Kinase Inhibitor Technology to deliver maximum results to our customers.
Development phase services such as process chemistry, cGMP synthesis and bioanalytical are available on a fee for service project basis. SCYNEXIS has tailored our development teams to be especially effective in moving your project from discovery to the clinic. By linking good science with regulatory compliance, SCYNEXIS ensures projects are completed to meet both a client’s expectations and current GMP/GLP guidelines.
|
RSS Feeds
